butylscopolammonium bromide has been researched along with Intestinal Obstruction in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, S; Li, S; Peng, X; Wang, P; Zhang, G | 1 |
| Horie, T; Imai, Y; Kwee, TC; Luijten, PR; Sadahiro, S; Takahara, T; Toyoguchi, Y; Yamashita, T; Yoshizako, T | 1 |
| Bükki, J; Klein, C; Ostgathe, C; Stiel, S | 1 |
| Akhtar, J; Soomro, MA | 1 |
| VANNUCCHI, C | 1 |
| Edmonds, P; Lucas, C | 1 |
| Casuccio, A; Mangione, S; Mercadante, S | 1 |
| Mercadante, S | 1 |
| Caraceni, A; De Conno, F; Messina, L; Ripamonti, C; Spoldi, E; Ventafridda, V | 1 |
| Caraceni, A; De Conno, F; Spoldi, E; Ventafridda, V; Zecca, E | 1 |
2 review(s) available for butylscopolammonium bromide and Intestinal Obstruction
| Article | Year |
|---|---|
[Pharmacological treatment of malignant bowel obstruction in severely ill and dying patients : a systematic literature review].
Topics: Adrenal Cortex Hormones; Butylscopolammonium Bromide; Cholinergic Antagonists; Evidence-Based Medicine; Gastrointestinal Neoplasms; Humans; Intestinal Obstruction; Octreotide; Palliative Care; Somatostatin; Terminal Care; Treatment Outcome | 2012 |
Medical treatment for inoperable malignant bowel obstruction: a qualitative systematic review.
Topics: Adrenal Cortex Hormones; Butylscopolammonium Bromide; Gastrointestinal Agents; Humans; Intestinal Obstruction; Muscarinic Antagonists; Neoplasms; Octreotide | 2007 |
2 trial(s) available for butylscopolammonium bromide and Intestinal Obstruction
| Article | Year |
|---|---|
Randomized clinical trial comparing octreotide and scopolamine butylbromide in symptom control of patients with inoperable bowel obstruction due to advanced ovarian cancer.
Topics: Butylscopolammonium Bromide; Female; Follow-Up Studies; Gastrointestinal Agents; Humans; Intestinal Obstruction; Liver Neoplasms; Middle Aged; Neoplasm Staging; Octreotide; Ovarian Neoplasms; Parasympatholytics; Peritoneal Neoplasms; Pleural Neoplasms; Prognosis; Prospective Studies; Severity of Illness Index | 2015 |
Non-operative management of intestinal obstruction due to ascaris lumbricoides.
Topics: Analysis of Variance; Animals; Ascariasis; Ascaris lumbricoides; Butylscopolammonium Bromide; Child; Enema; Female; Fluid Therapy; Humans; Intestinal Diseases, Parasitic; Intestinal Obstruction; Length of Stay; Male; Parasympatholytics; Saline Solution, Hypertonic | 2003 |
6 other study(ies) available for butylscopolammonium bromide and Intestinal Obstruction
| Article | Year |
|---|---|
Low b-value diffusion-weighted imaging for diagnosing strangulated small bowel obstruction: a feasibility study.
Topics: Adult; Aged; Area Under Curve; Butylscopolammonium Bromide; Diffusion; Diffusion Magnetic Resonance Imaging; Female; Humans; Image Processing, Computer-Assisted; Intestinal Obstruction; Intestine, Small; Jejunum; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Models, Statistical; ROC Curve | 2011 |
[Scopolamine N-butylbromide in the treatment of spastic dyskinesia of the digestive system in infants].
Topics: Butylscopolammonium Bromide; Child; Colon; Colonic Diseases; Constriction, Pathologic; Digestive System; Dyskinesias; Humans; Hydrocarbons, Brominated; Infant; Intestinal Obstruction; Muscle Spasticity; Pylorus; Scopolamine Derivatives | 1957 |
A trial that failed because of poor recruitment.
Topics: Butylscopolammonium Bromide; Clinical Trials, Phase II as Topic; Humans; Intestinal Obstruction; Multicenter Studies as Topic; Neoplasms; Patient Selection | 2003 |
Scopolamine butylbromide plus octreotide in unresponsive bowel obstruction.
Topics: Adult; Butylscopolammonium Bromide; Drug Therapy, Combination; Gastrointestinal Agents; Gastrointestinal Neoplasms; Humans; Intestinal Obstruction; Male; Muscarinic Antagonists; Octreotide; Pain | 1998 |
The management of inoperable gastrointestinal obstruction in terminal cancer patients.
Topics: Abdominal Neoplasms; Adult; Aged; Aged, 80 and over; Butylscopolammonium Bromide; Drug Administration Schedule; Female; Haloperidol; Home Care Services; Hospitalization; Humans; Intestinal Obstruction; Male; Middle Aged; Morphine; Pain; Palliative Care; Prospective Studies; Terminal Care; Vomiting; Xerostomia | 1990 |
Continuous subcutaneous infusion of hyoscine butylbromide reduces secretions in patients with gastrointestinal obstruction.
Topics: Aged; Butylscopolammonium Bromide; Drainage; Female; Genital Neoplasms, Female; Humans; Injections, Subcutaneous; Intestinal Obstruction; Intestinal Secretions; Intubation, Gastrointestinal; Middle Aged; Palliative Care | 1991 |